KAMRAN DARAVI CONSULTING LLC

Lobbying for MONTICELLO GROUP, LLC ON BEHALF OF DETROIT BIOPHARMA · Government Relations and Business Development Advisory Firm

Filing 4th Quarter - Amendment

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · $10,000.00 income · posted Jul 16, 2026

Lobbying activity 2

Manufacturing

Biopharma manufacturing, improve industrial supply chain to address shortages, advance technology, improve patient outcomes.

Health Issues

Biopharma manufacturing, improve industrial supply chain to address shortages, advance technology, improve patient outcomes.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.